SELINEXOR SYNERGISTICALLY PROMOTES THE ANTILEUKEMIA ACTIVITY OF AVAPRITINIB IN ACUTE MYELOID CELLS (AML) WITH AML1-ETO AND KIT MUTATION BY TARGETING PLK1 SIGNALING AND E2F SIGNALING

EHA Library, Liang-In Lin, 4161513

THE AML MUTANT QUARTET: DISSECTING THE TRANSCRIPTIONAL EFFECTS OF FLT3-ITD WITH ALKBH5-KO AND TET2 AND IDH2 MUTATIONS IN HEMATOPOIETIC PRECURSORS

EHA Library, Alessandro Pilli, 4161514

STUDY OF METABOLIC POLYMORPHISMS AS PREDICTORS OF CYTARABINE TOXICITY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Anna Sicuranza, 4161515

IMMUNOPHENOTYPIC AND IMMUNOTRANSCRIPTOMIC CHARACTERIZATION REVEALS DIFFERENTIAL ACUTE MYELOGENOUS LEUKEMIA LIPIDOMIC DEPENDENCIES.

EHA Library, Gustavo Rivero, 4161517

THE ROLE OF KRIT IN HEMATOLOGICAL DISEASES: MODULATION AND RESPONSE TO CLINICAL TREATMENTS

EHA Library, Cristina Panuzzo, 4161518

EVALUATION OF NOVEL STRUCTURES AS POTENTIAL FLT3 INHIBITORS IN AML

EHA Library, Jan Rataj, 4161519

FACTORS PREDICTING MYELODYSPLASTIC SYNDROME (MDS) TRANSFORMATION TO ACUTE MYELOGENOUS LEUKEMIA (AML), GENETIC DEFECTS AND CHROMOSOMAL ABNORMALIES

EHA Library, Maher Salamoon, 4161520

RETROSPECTIVE ANALYSIS OF OUTCOMES OF SHORTER COURSE OF VENETOCLAX WITH HYPOMETHYLATING AGENT IN NEWLY DIAGNOSED PATIENTS OF AML - SINGLE CENTRE EXPERIENCE

EHA Library, Bhavani Mandava, 4161521

TAILORING THE MOLECULAR PATTERN OF ACUTE MYELOID LEUKEMIA WITH EXTRAMEDULLARY INVOLVEMENT (EM-AML) UNVEILS THE PIVOTAL ROLE OF MESENCHYMAL STROMAL CELLS (MSCS) IN SUPPORTING DISEASE PROGRESSION

EHA Library, Giorgia Silvestrini, 4161522

HYPOXIA SUPPORTS INFLAMMATION-MEDIATED ENDOTHELIAL CELL ACTIVATION IN AML

EHA Library, Nikola Pantic, 4161523

THERAPEUTIC POTENTIAL OF NIRAPARIB, CCT245737, AND CONVENTIONAL THERAPY COMBINATIONS IN ACUTE MYELOBLASTIC LEUKEMIA: A PRELIMINARY IN VITRO STUDY

EHA Library, Ana Bela Sarmento-Ribeiro, 4161524

REALGAR-INDIGO NATURALIS FORMULA EXERTS AN ANTI-TUMOR EFFECT IN TUMOR-BEARING NUDE MICE BY ENHANCING THE AUTOPHAGY LEVEL TO PROMOTE THE APOPTOSIS OF ARSENIC-RESISTANT TUMOR CELLS.

EHA Library, Li Hou, 4161525

MULTIDRUG RESISTANCE AND METABOLIC REPROGRAMMING IN FLT3 MUTANT AML FOLLOWING PROLONGED FLT3 INHIBITOR TREATMENT

EHA Library, Lívia Bassani Lins de Miranda, 4161526

EPIGENETIC PERTURBATION OF PEDIATRIC AND ADULT ACUTE MYELOID LEUKEMIA AS A NEW APPROACH TO TARGET LEUKEMIC STEM CELLS

EHA Library, Cecilia Reyneri, 4161527

DETERMINING THE INVOLVEMENT OF THE HEDGEHOG SIGNALING PATHWAY IN THE DEVELOPMENT OF RESISTANCE AGAINST VENETOCLAX IN ACUTE MYELOID LEUKEMIA

EHA Library, Hager Abouelnaga, 4161528

COPY NEUTRAL LOH OF KITLG GENE IS ASSOCIATED WITH A LOWER REMISSION RATE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA.

EHA Library, Dmitry Bessmertniy, 4161529

INVESTIGATING BCL2 EXPRESSION VIA IMMUNOHISTOCHEMISTRY ON BONE MARROW BIOPSY AS A PROGNOSTIC MARKER FOR RESPONSE OF ACUTE MYELOID LEUKAEMIA TO VENETOCLAX

EHA Library, Zainab Ridha, 4161530

CRUCIAL ROLE OF NEXT GENERATION SEQUENCING IN THE PROGNOSTIC RECLASSIFICATION OF INTERMEDIATE-RISK ACUTE MYELOID LEUKEMIAS: THE SIENA HEMATOLOGY EXPERIENCE

EHA Library, Anna Sicuranza, 4161531

ACQUIRED FACTOR VII DEFICIENCY (AFVIID) ASSOCIATED WITH ACUTR LEUKEMIA (AL), A CASE SERIES FROM MONASTIR, TUNISIA

EHA Library, Ahlem Slama, 4161532

DECODING RTK-RAS SIGNALING IN AML: FROM GENETIC ALTERATIONS TO POTENTIAL THERAPEUTIC TARGETS

EHA Library, Pranay Tanwar, 4161533

FERULIC ACID ATTENUATES PROLIFERATION VIA MAPK/ERK PATHWAY IN ACUTE MYELOID LEUKEMIA

EHA Library, Chengling Zhang, 4161534

CLADRIBINE AS POTENTIAL PERSONALIZED TREATMENT FOR IDH1/2-MUTANT AML - AN IN SILICO INVESTIGATION

EHA Library, Zuzanna Nowicka, 4161536

INTEREST OF IMMATURE FRACTION OF RETICULOCYTES IN THE MONITORIONG OF HEMATOLOGICAL RECOVERY POST-CHEMOTHERAPY IN CANCER PATIENTS

EHA Library, Amine Moueden, 4161537

CXCR4 EXPRESSION ON LEUKEMIC BLASTS OF AML PATIENTS IN PERIPHERAL BLOOD AND BONE MARROW: IMPACT OF CRYOPRESERVATION AND GENETIC CORRELATIONS

EHA Library, Andreas Rank, 4161538

DNA DAMAGE RESPONSE GENE EXPRESSION ANALYSIS IN ELDERLY AML PATIENTS TREATED WITH HMAS AND VENETOCLAX.

EHA Library, Agni Vitsioti, 4161539

ACUTE MEGAKARYOBLASTIC LEUKEMIA LAMK: A CASE REPORT FROM THE HÔPITAL MILITAIRE D'INSTRUCTION MOHAMMED V (HMIMV)

EHA Library, Nadia Bennai, 4161540

IDENTIFICATION OF IMMUNE MODULATORS OF CAR-T CELLS TARGETING CD33 IN ACUTE MYELOID LEUKEMIA

EHA Library, Hugo Legenne, 4161541

STUDY OF MOLECULAR AND CLINICAL PROFILE OF PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA AND ITS OUTCOME

EHA Library, Omkar Choudhari, 4161542

AMINO ACID METABOLIC ADAPTATIONS IN AML: INSIGHTS FROM NOVEL PEGCRISANTASPASE AND VENETOCLAX THERAPY

EHA Library, Ashkan Emadi, 4161543

ANTI-TUMOR ACTIVITY AND RESTORATION OF HEMATOPOIESIS ACHIEVED WITH TAGRAXOFUSP IN PATIENTS WITH TREATMENT-NAÏVE BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN): PIVOTAL TRIAL SUBANALYSIS

EHA Library, Marina Konopleva, 4161544

SUBGROUP ANALYSIS BY FITNESS CRITERIA OF PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM TREATED WITH FIRST-LINE TAGRAXOFUSP

EHA Library, Naveen Pemmaraju, 4161545

IMPROVED TREATMENT OUTCOMES WITH CLADRIBINE, IDARUBICIN, CYTARABINE, AND VENETOCLAX (CLIA-VEN) OVER CONVENTIONAL 7+3 CHEMOTHERAPY IN DE NOVO ACUTE MYELOID LEUKEMIA

EHA Library, Kiran Naqvi, 4161546

V-RULES: REAL-WORLD EFFECTIVENESS AND SAFETY OF CPX-351 IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA

EHA Library, Thomas Leblanc, 4161547

REEVALUATING MDRM MUTATIONS IN DE NOVO AML PROGNOSIS WITH A SINGLE-CENTRE REAL-WORLD EXPERIENCE IN CHINA

EHA Library, Ning Liu, 4161548

USE OF HETERODUPLEX ANALYSIS FOR SCREENING 4BP INSERTIONS IN THE NPM1 GENE IN AML PATIENTS

EHA Library, Tatiana Subbotina, 4161549

PATTERNS OF POST-REMISSION THERAPY DE-ESCALATION IN ACUTE MYELOID LEUKEMIA PATIENTS IN REMISSION RECEIVING ONGOING CYCLES OF VENETOCLAX AND HYPOMETHYLATING AGENTS

EHA Library, Jonathan Canaani, 4161550

MECOM-REARRANGED AML SHOWS LOW RESPONSE RATES TO HYPOMETHYLATING AGENTS PLUS VENETOCLAX

EHA Library, Giorgio Gramazio, 4161551

PROGNOSTIC AND THERAPEUTIC IMPLICATIONS OF EARLY ASSESSMENT IN R/R AML AND HIGH-RISK MDS PATIENTS TREATED WITH SELINEXOR IN COMBINATION WITH VENETOCLAX AND AZACITIDINE

EHA Library, Shuai Su, 4161552

OUTCOMES OF ACUTE MYELOID LEUKEMIA: DOES SECONDARY LEUKEMIA MATTER?

EHA Library, Lu Yu, 4161553

CLADRIBINE FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA - A REAL-WORLD MULTICENTER RETROSPECTIVE STUDY.

EHA Library, Maya Zlotnick, 4161554

CLINICAL OUTCOMES OF AML PATIENTS UNDERGOING LESS INTENSIVE TREATMENT WITH VENETOCLAX AND REQUIRING INTENSIVE CARE UNIT ADMISSION IN A COMPREHENSIVE CANCER CENTER

EHA Library, Louison Brac De La Perriere, 4161555

INTEGRATION OF NEXT-GENERATION SEQUENCING IN THE DETECTION OF MEASURABLE RESIDUAL DISEASE AND PROGNOSTIC STRATIFICATION IN ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC NEOPLASMS, FROM INDUCTION THERAPY TO ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

EHA Library, Elena Crisà, 4161556

THE IMPACT OF MEASURABLE RESIDUAL DISEASE ON OUTCOMES IN PATIENTS WITH FLT3-ITD MUTATED ACUTE MYELOID LEUKEMIA

EHA Library, Onyee Chan, 4161557

CLINICAL EFFICACY ANALYSIS OF DECITABINE COMBINED WITH THE STANDARD INDUCTION REGIMEN IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Yi Wang, 4161558

ASSOCIATION OF VENETOCLAX TO MEC CHEMOTHERAPY IN FIT PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Corrado Zuanelli Brambilla, 4161559

UPDATES FROM A SINGLE-CENTER PHASE 2 STUDY OF PD-1 INHIBITOR COMBINED WITH DNA HYPOMETHYLATION AGENT + CAG REGIMEN IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Xiao-Ning Gao, 4161560

HOW TO IMPROVE THE EFFICACY OF VENETOCLAX AND AZACITIDINE(VA)FOR AML WITH A MONOCYTIC PHENOTYPE?

EHA Library, Xiaowen Tang, 4161561

CHART REVIEW STUDY ON THE REAL-WORLD CYTOPENIA MANAGEMENT OF PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH VENETOCLAX AND HYPOMETHYLATING AGENTS

EHA Library, Yuexi Wang, 4161562

MANNITOL AND ARSENIC TRIOXIDE COMBINATION THERAPY IMPROVES PROGNOSIS IN ACUTE PROMYELOCYTIC LEUKEMIA PATIENTS WITH CENTRAL NERVOUS SYSTEM RELAPSE

EHA Library, Yubing Zhao, 4161563

DECEASED DONOR BONE MARROW TRANSPLANT: FIRST EVER HUMAN CASE REPORT OF SUCCESSFUL ENGRAFTMENT AFTER INFUSION OF A CRYOPRESERVED DECEASED DONOR BONE MARROW IN A PATIENT WITH AML

EHA Library, Sagar Munjal, 4161564

GO-FIRST: REAL-WORLD DATA OF FRONT LINE GEMTUZUMAB OZOGAMICIN IN INTERMEDIATE AND FAVORABLE RISK AML PATIENTS IN A MULTICENTER RETROSPECTIVE CHART REVIEW

EHA Library, Wolfgang Sperr, 4161565

A PHASE 2 STUDY OF OLUTASIDENIB IN RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA: OUTCOMES BY NUMBER OF PRIOR TREATMENT REGIMENS

EHA Library, Stéphane De Botton, 4161566

STUDY OF DNA METHYLATION LEVELS IN JMML PATIENTS AND ITS CLINICAL SIGNIFICANCE

EHA Library, chenmeng Liu, 4161567

GENETIC DIVERSITY IN ACUTE MYELOID LEUKEMIA: THEINFL UENCE OF EUROPEAN ANCESTRY ON PROGNOSIS IN AHISPANIC COHORT

EHA Library, Juan Ontiveros-Austria, 4161568

IMPACT-AML: A EUROPEAN RANDOMIZED PRAGMATIC CLINICAL TRIAL OPTIMIZING TREATMENT FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKAEMIA

EHA Library, Giovanni Martinelli, 4161569

CLADRIBINE, LOW-DOSE CYTARABINE, AND VENETOCLAX IN ACUTE MYELOID LEUKEMIA RELAPSED OR REFRACTORY TO VENETOCLAX

EHA Library, Alexander Li, 4161570

EFFECTIVENESS OF PRIMARY ANTIFUNGAL PROPHYLAXIS IN ACUTE MYELOID LEUKEMIA PATIENTS TREATED WITH VENETOCLAX-BASED LOW-INTENSITY THERAPY

EHA Library, Ana Basquiera, 4161571

ON- AND OFF-TRIAL EXPERIENCE SUPPORTS FRACTIONATED GEMTUZUMAB OZOGAMICIN WITH HIDAC-BASED INDUCTION CHEMOTHERAPY IS SAFE AND HIGHLY EFFECTIVE FOR NEWLY DIAGNOSED FAVORABLE RISK AML.

EHA Library, Brenda Castillo, 4161572

COMPARATIVE EFFECTIVENESS OF OLUTASIDENIB AND IVOSIDENIB IN MIDH1 RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA PATIENTS POST-VENETOCLAX: INSIGHTS FROM 2102-HEM-101 AND A REAL-WORLD EXTERNAL CONTROL

EHA Library, Jorge Cortes, 4161573

EFFICACY AND SAFETY OF MITOXANTRONE HYDROCHLORIDE LIPOSOME COMBINED WITH MODIFIED VA REGIMEN IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA: A SINGLE-ARM, MULTI-CENTER STUDY

EHA Library, Jin Yin, 4161574

GEMTUZUMAB OZOGAMICIN AS FIRST LINE TREATMENT OF ACUTE MYELOID LEUKAEMIA (AML) WITH FAVOURABLE PROGNOSIS - A REAL LIFE NATIONAL EXPERIENCE FROM GRUPO PORTUGUÊS DE LEUCEMIAS AGUDAS (GLPA)

EHA Library, Sara Vaz da Silva, 4161575

CLINICAL CASE ANALYSIS OF 21 PATIENTS WITH BPDCN AND PDC-AML

EHA Library, Jinjun Yang, 4161576

MEASURABLE RESIDUAL DISEASE ASSESSMENT PRIOR TO ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES: A 20-YEAR MONOCENTRIC STUDY.

EHA Library, Alexandre-Raphael Wery, 4161577

„HIT RIGHT AND EARLY” IN AML PATIENTS WITH FLT3-ITD/NPM1/DNMT3A TRIPLE MUTATIONS

EHA Library, Ruixin Li, 4161578

CLINICAL STUDY OF PORCINE ANTI-HUMAN LYMPHOCYTE IMMUNOGLOBULIN COMBINED WITH CYCLOPHOSPHAMIDE IN HEMATOPOIETIC STEM CELL TRANSPLANTATION OF MYELOID MALIGNANCIES

EHA Library, Yali Zhou, 4161579

THE POWER OF ISTH SCORE AND ITS MODIFICATIONS TO PREDICT BLEEDING IN AML PATIENTS PRESENTING WITH DIC

EHA Library, Bedrettin Orhan, 4161581

CLINICAL AND GENETIC FACTORS ASSOCIATED WITH PROGNOSTIC DETERMINATION IN CBF-AML: RESULTS FROM A THAI ACUTE LEUKEMIA WORKING GROUP

EHA Library, Quoc Nguyen, 4161583

LONG-TERM OUTCOMES OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR THERAPY-RELATED ACUTE MYELOID LEUKEMIA: AN 11-YEAR SINGLE-CENTER COHORT STUDY

EHA Library, Yue Lu, 4161584

IMPACT OF NK RECEPTOR AND LIGAND GENE EXPRESSION IN ACUTE MYELOID LEUKEMIA: A COMPUTATIONAL APPROACH

EHA Library, Camila Garcia, 4161585

MYELOID SARCOMA AND ELN RISK GROUP

EHA Library, Manish Jain, 4161586

TREATMENT PATTERNS IN PATIENTS WITH RELAPSED OR REFRACTORY NPM1 MUTATED ACUTE MYELOID LEUKEMIA IN THE UNITED STATES: A REAL-WORLD DATA ANALYSIS

EHA Library, Huan Huang, 4161587

MITOXANTRONE HYDROCHLORIDE LIPOSOME IN COMBINATION WITH CYTARABINE AND VENETOCLAX (MAV) REGIMEN IN RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Huafeng Wang, 4161589

G6PD-DEFICIENCY IS ASSOCIATED WITH IMPROVED SURVIVAL IN PATIENTS WITH AML TREATED WITH VENETOCLAX AND AZACITIDINE

EHA Library, Shira Buchrits, 4161590

PROGNOSTIC IMPLICATIONS OF TP53 MUTATIONS IN ACUTE MYELOID LEUKEMIA: A CRITICAL CONCERN

EHA Library, Linya Wang, 4161591

STEROL REGULATORY ELEMENT-BINDING TRANSCRIPTION FACTOR 2 EXPRESSION IS ASSOCIATED WITH ADVERSE OUTCOME IN CYTOGENETICALLY NORMAL ACUTE MYELOID LEUKEMIA

EHA Library, Sai Huang, 4161592

EFFICACY OF CPX-351 IN SECONDARY ACUTE MYELOID LEUKEMIA DEFINED ACCORDING TO WHO 2022 CLASSIFICATION.

EHA Library, Fabio Guolo, 4161593

EFFICACY AND SAFETY OF LIPOSOMAL MITOXANTRONE IN RELAPSED/REFRACTORY ACUTE MYELOID LEUKAEMIA PATIENTS WITHOUT PRIOR EXPOSURE

EHA Library, Kaibo Zhu, 4161594

TREATMENT OF 317 ELDERLY UNFIT PATIENTS WITH AML: RESULTS FROM A SINGLE CENTER

EHA Library, Andrea Kündgen, 4161595

IMPACT OF THE GERIATRIC MULTIDIMENSIONAL ASSESSMENT (GMA) IN ELDERLY AML PATIENTS TREATED WITH HYPOMETHYLATING AGENTS AT THE ANCONA HEMATOLOGY CLINIC*.

EHA Library, Debora Capelli, 4161596

VENETOCLAX PLUS DECITABINE, CYTARABINE, ACLARUBICIN, AND G-CSF IN ADULTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: A MULTICENTER, RETROSPECTIVE STUDY

EHA Library, Yuping Gong, 4161597

IVOSIDENIB COMBINED WITH VENETOCLAX AND AZACITIDINE FOR THE TREATMENT OF NEWLY DIAGNOSED IDH1-MUTANT ACUTE MYELOID LEUKEMIA: A PROSPECTIVE, TWO COHORTS, MULTICENTER STUDY

EHA Library, Haiping Dai, 4161598

PEDIATRIC LANGERHANS CELL HISTIOCYTOSIS (LCH) IN UZBEKISTAN: ANALYSIS OF PROGNOSTIC FACTORS AND OUTCOMES.

EHA Library, Khilola Rustamova, 4161599

STREAM: CREATION AND TECHNICAL IMPLEMENTATION FOR A MULTICENTRE PATIENT REGISTRY FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKAEMIA

EHA Library, Kalia Orphanou, 4161600

CLINICAL IMPACT OF RESIDUAL GENETIC MUTATIONS AT CR IN ACUTE MYELOID LEUKEMIA

EHA Library, Xin Yan, 4161601

MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC) OF OLUTASIDENIB (OLU) AND IVOSIDENIB (IVO) IN ISOCITRATE DEHYDROGENASE 1 (IDH1)-MUTATED RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Jorge Cortes, 4161602

IMMUNOPHENOTYPIC DIFFERENCES BETWEEN INITIAL PRESENTATION AND INDUCTION THERAPY IN ACUTE MEGAKARYOBLASTIC LEUKEMIA

EHA Library, Hui Wang, 4161603

POST-INDUCTION MRD PREDICTS MOLECULAR RELAPSE IN FAVORABLE-RISK, INTENSIVELY-TREATED NPM1-MUTATED AML

EHA Library, Marco Petrella, 4161604

EFFECT OF RNA SPLICEOSOME MUTATIONS ON OUTCOME AND SURVIVAL OF PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Tao Wu, 4161605

A PHASE 2 STUDY OF CHIDAMIDE IN COMBINATION WITH CAG AND VENETOCLAX-AZACITIDINE IN ELN ADVERSE-RISK ACUTE MYELOID LEUKEMIA

EHA Library, Lei Lv, 4161606

VENETOCLAX-BASED REGIMENS VERSUS INTENSIVE CHEMOTHERAPY AS A BRIDGE TO ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH THERAPY-RELATED ACUTE MYELOID LEUKEMIA

EHA Library, Ekaterina Romaniuk, 4161608

ACUTE MYELOID LEUKEMIA IN HIGH DISEASE BURDEN REGIONS: ANALYSIS OF HEALTHCARE CAPACITY AND COMORBIDITIES IN WESTERN EUROPE, NORTH AMERICA, AND EAST ASIA

EHA Library, Zhangjie Chen, 4161609

FLAG-IDA AND VENETOCLAX IN RELAPSED / REFRACTORY ACUTE MYELOID LEUKEMIA IN AN ASIAN POPULATION

EHA Library, Joshua Tan, 4161610

PROGNOSTIC IMPACT OF HIGH-RISK MUTATIONS IN SECONDARY ACUTE MYELOID LEUKEMIA PATIENTS TREATED WITH CPX-351: INSIGHTS INTO MOLECULAR PATTERNS AND TREATMENT RESPONSE

EHA Library, Carola Riva, 4161611

MOLECULAR BACKGROUND OF NPM1-MUTATED ACUTE MYELOID LEUKEMIA RECEIVING INTENSIFIED FLUDARABINE-BASED INDUCTION: EXPLORING THE ROLE OF „SECONDARY TYPE” AND HIGH RISK MUTATIONS

EHA Library, Paola Minetto, 4161612

GENOMIC CHARACTERIZATION OF PEDIATRIC ACUTE MYELOID LEUKEMIA PATIENTS BY NGS IN UKRAINE

EHA Library, Nataliia Levkovych, 4161613

IMPACT OF THE DASATINIB USED BEFORE ALLOHCT ON THE OUTCOME OF CHILDREN WITH CORE BINDING FACTOR ACUTE MYELOID LEUKEMIA

EHA Library, Lipeng Liu, 4161614

THE EFFICACY AND SURVIVAL ANALYSIS OF FIT-AML PATIENTS TREATED WITH VENETOCLAX COMBINED WITH HYPOMETHYLATING AGENTS (VEN-HMAS)

EHA Library, Xiaojing Yan, 4161615

ANALYSIS OF CLINICAL AND PROGNOSTIC CHARACTERISTICS OF CHILDREN WITH ACUTE MYELOID LEUKEMIA ACCOMPANIED BY MYELODYSPLASTIC-RELATED GENES MUTATIONS

EHA Library, Zihao Xia, 4161616

PROLONGED OVERALL SURVIVAL WITH VENAZA IN AN UNSELECTED REAL-WORLD POPULATION IRRESPECTIVE OF FITNESS FOR INTENSIVE CHEMOTHERAPY

EHA Library, Marta Pereira, 4161617

OUTCOMES OF REAL-WORLD INVESTIGATIONS ON AZACITIDINE PLUS VENETOCLAX IN ACUTE MYELOID LEUKEMIA:ORION-AML STUDY

EHA Library, Thanawat Rattanathammethee, 4161618